NEW YORK (
) -- The new
Claymore/AlphaShares China All-Cap ETF
offers broader access to China than the widely known
iShares FTSE/Xinhua China 25 Index Fund
. The Claymore fund has 99 holdings, four times that of the iShares fund, and the exchange traded fund has stakes in small- and mid-cap stocks, not only mega caps.
While that's the Claymore ETF's billing, something appears to get lost in the implementation. The 13 largest holdings, which account for 49% of assets, are the big Chinese stocks you have known for years, like
China Life Insurance
(PTR - Get Report)
. The top 10s of each fund have six names in common. At the industry level, both are heaviest in financials, at 35% for the Claymore fund and 51% for the iShares ETF.
That both funds are dominated by financials is a potential risk. The bear case for China focuses on how much growth is coming from government spending and whether the Chinese stimulus plan is sowing the seeds of a lending bubble similar to what occurred in the U.S. Some would also add the lack of potable water and demographic issues as other looming problems. While those risk factors would make for a good debate, if they play out negatively, the financials would seem most likely to be adversely affected.
From a big-picture view, China is new to capitalism, so it makes sense to expect that there will be policy mistakes that serve to mismanage the growth story, which, again, threatens financials more than most other sectors. I believe it makes more sense to go narrower, focusing on internal growth, modernization and general improvement of living conditions, while avoiding some of the more obvious risks. Tying into this idea, I would want to avoid companies or funds that rely on exports. Exporters and associated companies rely on the health of the U.S. consumer, which may not be a great bet these days.